
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 263
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 263
Showing 26-50 of 263 citing articles:
Acetyl-CoA metabolic accumulation promotes hepatocellular carcinoma metastasis via enhancing CXCL1-dependent infiltration of tumor-associated neutrophils
Junjie Pan, Sun‐Zhe Xie, Xin Zheng, et al.
Cancer Letters (2024) Vol. 592, pp. 216903-216903
Closed Access | Times Cited: 5
Junjie Pan, Sun‐Zhe Xie, Xin Zheng, et al.
Cancer Letters (2024) Vol. 592, pp. 216903-216903
Closed Access | Times Cited: 5
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma
Feifan Yao, Suiqing Zhou, Ruizhi Zhang, et al.
Cancer Letters (2024) Vol. 593, pp. 216935-216935
Closed Access | Times Cited: 5
Feifan Yao, Suiqing Zhou, Ruizhi Zhang, et al.
Cancer Letters (2024) Vol. 593, pp. 216935-216935
Closed Access | Times Cited: 5
Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma
Jiaxin Han, Wentao Kuai, Liu Yang, et al.
Cancer Biology and Medicine (2024), pp. 1-13
Open Access | Times Cited: 5
Jiaxin Han, Wentao Kuai, Liu Yang, et al.
Cancer Biology and Medicine (2024), pp. 1-13
Open Access | Times Cited: 5
Zero-Crosstalk Tumor-Targeting Ratiometric Near-Infrared γ-Glutamyltranspeptidase Probe for Fluorescent-Guided Surgical Resection of Orthotopic Hepatic Tumor
Zhichao Yang, ZhiHao Yang, Zhiqiang Wang, et al.
Analytical Chemistry (2025)
Closed Access
Zhichao Yang, ZhiHao Yang, Zhiqiang Wang, et al.
Analytical Chemistry (2025)
Closed Access
Seeing beyond words: nanotechnology in hepatocellular carcinoma - a bibliometric study
Talaiti Tuergan, Aimitaji Abulaiti, Alimu Tulahong, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Talaiti Tuergan, Aimitaji Abulaiti, Alimu Tulahong, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Exploring early postoperative core symptoms in Chinese patients with primary liver cancer: a cross-sectional and longitudinal network analysis
Haoran Zhang, Shaoxue Li, Mengmeng Yuan, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Closed Access
Haoran Zhang, Shaoxue Li, Mengmeng Yuan, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 2
Closed Access
Radioembolization prior to liver resection may increase the risk of severe biliary complications: a multicenter, retrospective cohort study performed in France.
Céline Dananai, Marie Alaux, Éric Vibert, et al.
Surgical Oncology (2025) Vol. 58, pp. 102186-102186
Open Access
Céline Dananai, Marie Alaux, Éric Vibert, et al.
Surgical Oncology (2025) Vol. 58, pp. 102186-102186
Open Access
Advances, challenges and future applications of liver organoids in experimental regenerative medicine
Da Gong, Jian Mo, Mei Zhi Zhai, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Da Gong, Jian Mo, Mei Zhi Zhai, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study
Zhaoqian He, Hua Chen, Liang Chen, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 51-63
Open Access
Zhaoqian He, Hua Chen, Liang Chen, et al.
ImmunoTargets and Therapy (2025) Vol. Volume 14, pp. 51-63
Open Access
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Impact of the revised Japanese indication criteria for deceased donor liver transplantation on liver cirrhotic patients of Child–Pugh classification B with hepatocellular carcinoma
Akihiro Seki, Tatsuya Yamashita, Takeshi Terashima, et al.
Hepatology Research (2025)
Closed Access
Akihiro Seki, Tatsuya Yamashita, Takeshi Terashima, et al.
Hepatology Research (2025)
Closed Access
Classification of Hepatic Nodules Using an Improved WOA‐SVM Radiomics Model
H. Sun, Lijia Wang
International Journal of Imaging Systems and Technology (2025) Vol. 35, Iss. 2
Closed Access
H. Sun, Lijia Wang
International Journal of Imaging Systems and Technology (2025) Vol. 35, Iss. 2
Closed Access
Using Signal Off-to-On Strategy for Designing Precise and Ultrasensitive Biosensor Towards Tumor Through Protein Variant Detection Based on Biocompatible Bimetallic Mof
Zhihui Dai, Wenwen Tu, Huan Liu, et al.
(2025)
Closed Access
Zhihui Dai, Wenwen Tu, Huan Liu, et al.
(2025)
Closed Access
Effect of Narrow-Margin Hepatectomy Combined with Intraoperative Radiotherapy on Long-Term Prognosis of Patients with Centrally Located Hepatocellular Carcinoma: A Propensity Score Matching Analysis
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Changcheng Tao, Liguo Liu, Nan Hu, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 261-274
Open Access
Unexpected Spontaneous Regression of Extensively Diffused Hepatocellular Carcinoma
T Hirata, Shinya Endo, Naofumi Shirane, et al.
Cureus (2025)
Open Access
T Hirata, Shinya Endo, Naofumi Shirane, et al.
Cureus (2025)
Open Access
Potential indications for liver transplant in Child–Pugh A and Model for End‐stage Liver Disease exception for hepatocellular carcinoma in Japan
Ryoichi Goto, Tsuyoshi Shimamura, Tomoaki Nakajima, et al.
Hepatology Research (2025)
Closed Access
Ryoichi Goto, Tsuyoshi Shimamura, Tomoaki Nakajima, et al.
Hepatology Research (2025)
Closed Access
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Validation of two prognostic gene scores in patients undergoing liver resection for hepatocellular carcinoma
Stefan Schnabl, Jeanett Klubien, Colm J. O’Rourke, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102544-102544
Open Access
Stefan Schnabl, Jeanett Klubien, Colm J. O’Rourke, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102544-102544
Open Access
Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism
Ning Wang, Siming Lu, Ziyi Cao, et al.
Cell Metabolism (2025)
Open Access
Ning Wang, Siming Lu, Ziyi Cao, et al.
Cell Metabolism (2025)
Open Access
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 12
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, et al.
Cancer Biology and Medicine (2023), pp. 1-19
Open Access | Times Cited: 12
Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
Lin Jia, Yang Yang, Feng Sun, et al.
Cellular Signalling (2024) Vol. 115, pp. 111035-111035
Closed Access | Times Cited: 4
Lin Jia, Yang Yang, Feng Sun, et al.
Cellular Signalling (2024) Vol. 115, pp. 111035-111035
Closed Access | Times Cited: 4
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma
Tennyson P. Rayginia, Chenicheri K. Keerthana, Sadiq C. Shifana, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5199-5221
Closed Access | Times Cited: 4
Tennyson P. Rayginia, Chenicheri K. Keerthana, Sadiq C. Shifana, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5199-5221
Closed Access | Times Cited: 4
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
Shabnam Malik, Mohammed Sikander, Mohd Wahid, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 4
Shabnam Malik, Mohammed Sikander, Mohd Wahid, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 4
Y Zhang, Liyi Zou, Xiaodan Li, et al.
WIREs Mechanisms of Disease (2024) Vol. 16, Iss. 4
Closed Access | Times Cited: 4
Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis
Yiqi Xiong, Yonghong Zhang, Caixia Hu
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1807-1820
Open Access | Times Cited: 4
Yiqi Xiong, Yonghong Zhang, Caixia Hu
Translational Cancer Research (2024) Vol. 13, Iss. 4, pp. 1807-1820
Open Access | Times Cited: 4